Max Helfert is a Master’s in Finance student at USC, pursuing a career in equity research. He specializes in healthcare innovation, leveraging a bottom-up approach to identify high-growth ...

Gorman-Rupp has grown its operations. Read why I require confirmation of growth and/or pullback in GRC share price before reconsidering a neutral stance.

For Q4 2024, the John Hancock U.S. Growth Fund underperformed the benchmark Russell 1000 Growth Index. Click here to read the ...

TransMedics' NOP advances organ transplantation with improved outcomes & cost reductions. See why I rate TMDX stock a strong ...

London (UKX) -0.05% to 8,536. Germany (DAX:IND) -0.41% to 22,584.France (CAC:IND) -0.25% to 7,969.

For Q4 2024, the John Hancock U.S. Global Leaders Growth fund posted a small gain that trailed the return of its benchmark ...

Rapport Therapeutics focuses on developing specific small molecule therapies for CNS diseases. Check out my recommendation ...

Tesla's deferred FSD revenue and limited Robotaxi rollout show promise, but currently lack meaningful financial impact. Read ...

The John Hancock Seaport Long/Short Fund didn’t keep pace with its benchmark, the MSCI World Index for Q4 2024. Click here to ...

U.S. President Donald Trump on Sunday said that reciprocal tariffs he is set to announce this week will include all countries, and not just a smaller group of 10 to 15 nations.

DiDi Global (DIDIY) dominates China's shared mobility market with strong profitability growth and competitive advantages. See ...

The John Hancock Mortgage-Backed Securities ETF outperformed its benchmark, the Bloomberg U.S. MBS Index for Q4 2024. Click ...